- Control and Prevention of Tuberculosis (CAP-TB)*
- Regional Prospective Observational Research in Tuberculosis (RePORT) International Coordinating Center*
- China Tuberculosis Clinical Trials Consortium (CTCTC) project *
- Aspirin in Treating Patients with Colon Cancer*
- China Adherence through Technology Study (CATS)*
Stories and Highlights
- FHI 360 delivers uninterrupted tuberculosis care during the COVID-19 pandemic
- China Tuberculosis Clinical Trials Consortium will advance global TB knowledge
- Mobile application provides support to tuberculosis patients in China
- Bill Gates is briefed on Sino-implant (II) Grant
Contact
- Jacqueline McPherson
- Country Director (Acting)
- Beijing Representative Office
B110, Floor 4, Building 1, No. 15
Guang Hua Road, Chao Yang District
Beijing, China 100026- Telephone: +86. 108.588.5599
- FHI 360 Kunming Office
#1302B, Jin Tai Plaza
#48 East Dong Feng Road
Kunming 650051 China- Telephone: +86.871.363.3280
- Fax: +86.871.364.2267